Australian Statistics on Medicines 2011
Table 1 - Blood and Blood Forming Organs
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B01AA03 |
WARFARIN |
||||||
P |
2209G |
Tablet 2mg |
7.50 |
MG |
1,004,645 |
12,794,232 |
|
P |
2211J |
Tablet 5mg |
7.50 |
MG |
726,645 |
10,137,522 |
|
P |
2843P |
Tablet 1mg |
7.50 |
MG |
1,142,531 |
14,169,034 |
|
P |
2844Q |
Tablet 3mg |
7.50 |
MG |
333,939 |
4,198,194 |
|
HEPARIN GROUP |
|||||||
B01AB04 |
DALTEPARIN |
||||||
P |
2816F |
Inj 5,000 units (anti-Xa) in 0.2mL syringe |
2.50 |
TE |
6,875 |
485,015 |
|
P |
8269F |
Inj 10,000 units (anti-Xa) in 1mL syringe |
2.50 |
TE |
333 |
94,169 |
|
P |
8271H |
Inj 7,500 units (anti-Xa) in 0.75mL syringe |
2.50 |
TE |
278 |
63,280 |
|
P |
8603T |
Inj 2,500 units (anti-Xa) in 0.2mL syringe |
2.50 |
TE |
3,897 |
230,103 |
|
P |
8641T |
Inj 2,500 units (anti-Xa) in 0.2mL syringe |
2.50 |
TE |
1,434 |
117,702 |
|
P |
8642W |
Inj 5,000 units (anti-Xa) in 0.2mL syringe |
2.50 |
TE |
2,209 |
193,265 |
|
P |
8643X |
Inj 7,500 units (anti-Xa) in 0.75mL syringe |
2.50 |
TE |
313 |
47,400 |
|
B01AB05 |
ENOXAPARIN |
||||||
A |
18880 |
Inj 120mg (12000u anti-Xa) in 0.8mL syringe 10 |
2.00 |
TE |
112 |
- |
|
P |
5434B |
Inj 80mg (8000u anti-Xa) in 0.8 mL prefilled syringe 20 |
2.00 |
TE |
4,177 |
624,895 |
|
P |
5435C |
Inj 100mg (10000u anti-Xa) in 1 mL prefilled syringe 20 |
2.00 |
TE |
3,789 |
701,904 |
|
P |
8262W |
Inj 60mg (6000u anti-Xa) in 0.6mL syringe |
2.00 |
TE |
31,992 |
3,901,553 |
|
P |
8263X |
Inj 80mg (8000u anti-Xa) in 0.8mL syringe |
2.00 |
TE |
59,101 |
8,410,260 |
|
P |
8264Y |
Inj 100mg (10000u anti-Xa) in 1 mL syringe |
2.00 |
TE |
63,485 |
11,056,805 |
|
P |
8510X |
Inj 40mg (4000u anti-Xa) in 0.4 mL syringe 20 |
2.00 |
TE |
111,074 |
9,203,048 |
|
P |
8558K |
Inj 20mg (2000u anti-Xa) in 0.2mL syringe 20 |
2.00 |
TE |
39,612 |
2,939,908 |
|
P |
8639Q |
Inj 40mg (4000u anti-Xa) in 0.4mL syringe |
2.00 |
TE |
30,256 |
2,809,507 |
|
P |
8640R |
Inj 60mg (6000u anti-Xa) in 0.6mL syringe |
2.00 |
TE |
16,781 |
2,256,126 |
|
P |
8716R |
Inj 20mg (2000u anti-Xa) in 0.2mL syringe |
2.00 |
TE |
10,791 |
948,725 |
|
P |
9195Y |
Solution for injection 40mg (4000 i.u. anti-Xa) 20 |
2.00 |
TE |
15,398 |
1,546,216 |
|
P |
9196B |
Solution for injection 40mg (4000 i.u. anti-Xa) 20 |
2.00 |
TE |
6,679 |
645,930 |
|
B01AB01 |
HEPARIN SODIUM |
||||||
P |
1076P |
Injection 35,000 units in 35mL 12 |
10.00 |
TE |
1,207 |
296,910 |
|
P |
1463B |
Injection 5,000 units in 5mL |
10.00 |
TE |
8,548 |
548,041 |
|
P |
1466E |
Injection 5,000 units in 0.2mL |
10.00 |
TE |
43,174 |
678,478 |
|
PLATELET AGGREGATION INHIBITORS EXCL. HEPARIN |
|||||||
B01AC13 |
ABCIXIMAB |
||||||
P |
8048N |
I.V.injection 10mg in 5mL |
25.00 |
MG |
1,181 |
1,650,496 |
|
B01AC06 |
ASPIRIN |
||||||
A |
10544 |
Tablet 100mg 30 |
0.10 |
GM |
803 |
- |
|
A |
10599 |
Tablet 100mg 28 |
0.10 |
GM |
17,070 |
- |
|
A |
13020 |
Capsule 100mg 28 |
0.10 |
GM |
633 |
- |
|
P |
4076M |
Tablet 100mg (enteric coated) |
0.10 |
GM |
13,072 |
204,446 |
|
P |
4077N |
Tablet 100mg (enteric coated) |
0.10 |
GM |
85,663 |
1,171,836 |
|
P |
4078P |
Capsule 100mg (enteric coated pellets) |
0.10 |
GM |
11,529 |
168,299 |
|
ANTITHROMBOTIC AGENTS |
|||||||
P |
8202Q |
Tablet 100mg |
0.10 |
GM |
1,104,501 |
8,835,207 |
|
B01AC04 |
CLOPIDOGREL |
||||||
P |
4179Y |
Tablet 75mg (as hydrogen sulfate) 28 |
75.00 |
MG |
657 |
45,343 |
|
P |
5436D |
Tablet 75mg 28 |
75.00 |
MG |
425 |
27,212 |
|
P |
8358X |
Tablet 75mg (as hydrogen sulfate) 28 |
75.00 |
MG |
2,331,877 |
161,155,943 |
|
P |
9317J |
Tablet 75mg (as hydrogen sulfate) 28 |
75.00 |
MG |
119,971 |
8,287,333 |
|
P |
9354H |
Tablet 75mg (as hydrogen sulfate) 28 |
75.00 |
MG |
270,817 |
18,692,942 |
|
B01AC30 |
CLOPIDOGREL with ASPIRIN |
||||||
P |
9296G |
Tablet 75mg (as hydrogen sulfate)-100mg 30 |
- |
- |
510,540 |
38,192,131 |
|
B01AC07 |
DIPYRIDAMOLE |
||||||
A |
13040 |
Tablet 100mg 100 |
0.40 |
GM |
447 |
- |
|
P |
8335Q |
Capsule 200mg (sustained release) |
0.40 |
GM |
38,165 |
1,408,043 |
|
B01AC30 |
DIPYRIDAMOLE with ASPRIN |
||||||
P |
8382E |
Capsule 200mg (sustained release)-25mg |
- |
- |
501,828 |
18,620,884 |
|
B01AC16 |
EPTIFIBATIDE |
||||||
P |
8683B |
Solution for I.V. injection 20mg (base) in 10mL |
0.20 |
GM |
523 |
124,890 |
|
P |
8684C |
Solution for I.V. infusion 75mg (base) in 100mL |
0.20 |
GM |
373 |
321,179 |
|
B01AC22 |
PRASUGREL |
||||||
P |
9495R |
Tablet 5mg (as hydrochloride) 28 |
10.00 |
MG |
1,933 |
187,098 |
|
P |
9496T |
Tablet 10mg (as hydrochloride) 28 |
10.00 |
MG |
29,991 |
3,176,949 |
|
B01AC05 |
TICLOPIDINE HYDROCHLORIDE |
||||||
P |
2095G |
Tablet 250mg |
0.50 |
GM |
672 |
92,756 |
|
B01AC17 |
TIROFIBAN |
||||||
P |
8350L |
Solution concentrate I.V. infusion 12.5mg in 50mL |
10.00 |
MG |
1,309 |
509,350 |
|
ENZYMES |
|||||||
B01AD11 |
TENECTEPLASE |
||||||
P |
8527T |
Powder for injection 50mg with solvent |
40.00 |
MG |
207 |
435,079 |
|
DIRECT THROMBIN INHIBITORS |
|||||||
B01AE06 |
BIVALIRUDIN |
||||||
P |
8844L |
Powder for I.V. injection 250mg (base) |
0.25 |
GM |
2,540 |
1,809,429 |
|
B01AE07 |
DABIGATRAN |
||||||
A |
21574 |
Capsule 150mg (as mesilate) 60 |
0.22 |
GM |
356 |
- |
|
P |
9319L |
Capsule 110mg (as mesilate) 20 |
0.22 |
GM |
302 |
52,579 |
|
P |
9321N |
Capsule 110mg (as mesilate) 60 |
0.22 |
GM |
1,691 |
368,598 |
|
OTHER ANTITHROMBOTIC AGENTS |
|||||||
B01AX06 |
RIVAROXABAN |
||||||
P |
9465E |
Tablet 10mg 10 |
10.00 |
MG |
372 |
58,704 |
|
P |
9466F |
Tablet 10mg 15 |
10.00 |
MG |
2,844 |
569,024 |
|
P |
9467G |
Tablet 10mg 30 |
10.00 |
MG |
3,406 |
976,317 |
|
P |
9468H |
Tablet 10mg 10 |
10.00 |
MG |
758 |
77,254 |
|
P |
9469J |
Tablet 10mg 15 |
10.00 |
MG |
6,290 |
890,265 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B02AA02 |
TRANEXAMIC ACID |
||||||
P |
2180R |
Tablet 500mg |
2.00 |
GM |
46,396 |
2,379,392 |
|
VITAMIN K AND OTHER HAEMOSTATICS |
|||||||
VITAMIN K |
|||||||
B02BA01 |
PHYTOMENADIONE |
||||||
A |
16049 |
Ampoule 10mg/mL 5 |
20.00 |
MG |
1,511 |
- |
|
A |
16648 |
Ampoule 2mg/0.2mL 5 |
20.00 |
MG |
295 |
- |
|
OTHER SYSTEMIC HEMOSTATICS |
|||||||
B02BX04 |
ROMIPLOSTIM |
||||||
P |
9697J |
Powder for inj. 375ug (250ug in 0.5mL when reconstituted) |
30.00 |
UG |
230 |
675,482 |
|
P |
9699L |
Powder for inj. 625ug (500ug in 1mL when reconstituted) |
30.00 |
UG |
112 |
768,794 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B03AA02 |
FERROUS FUMARATE |
||||||
P |
8985X |
Tablet 200mg (equivalent to 65.7mg iron) 60 |
0.20 |
GM |
2,788 |
32,257 |
|
B03AA07 |
FERROUS SULPHATE |
||||||
A |
16996 |
Tablet |
0.20 |
GM |
57,944 |
- |
|
P |
8815Y |
Oral liquid 30mg per mL, 250mL |
0.20 |
GM |
44,392 |
869,040 |
|
IRON TRIVALENT, PARENTERAL PREPARATIONS |
|||||||
B03AC03 |
IRON POLYMALTOSE COMPLEX |
||||||
P |
2593L |
Injection 100mg (iron) in 2mL |
0.10 |
GM |
56,388 |
3,087,497 |
|
B03AC02 |
SACCHARATED IRON OXIDE |
||||||
P |
8807M |
Concent for soln for infus 2.7g =100mg iron in 5mL |
0.10 |
GM |
376 |
51,625 |
|
IRON IN COMBINATION WITH FOLIC ACID |
|||||||
B03AD02 |
FERROUS FUMARATE with FOLIC ACID |
||||||
P |
9011G |
Tablet 310mg-350ug |
- |
- |
260,664 |
3,321,226 |
|
B03AD03 |
FERROUS SULPHATE DRIED with FOLIC ACID |
||||||
A |
14528 |
Capsule 270mg-300ug (delayed release) |
- |
- |
1,664 |
- |
|
A |
18904 |
Tablet 270mg-300ug (sustained release) |
- |
- |
20,032 |
- |
|
VITAMIN B12 AND FOLIC ACID |
|||||||
VITAMIN B12 (CYANOCOBALAMIN AND DERIVATIVES) |
|||||||
B03BA03 |
HYDROXOCOBALAMIN |
||||||
P |
9048F |
Injection 1mg in 1mL 3 |
20.00 |
UG |
343,271 |
5,454,707 |
|
FOLIC ACID AND DERIVATIVES |
|||||||
B03BB01 |
FOLIC ACID |
||||||
P |
1437P |
Tablet 5mg |
- |
- |
114,647 |
1,556,450 |
|
P |
2958Q |
Tablet 500ug |
0.40 |
MG |
44,289 |
593,888 |
|
OTHER ANTIANAEMIC PREPARATIONS |
|||||||
OTHER ANTIANAEMIC PREPARATIONS |
|||||||
B03XA02 |
DARBEPOETIN ALPHA |
||||||
P |
6320P |
Injection 10ug in 0.4mL syringe 8 |
4.50 |
UG |
222 |
54,205 |
|
P |
6321Q |
Injection 20ug in 0.5mL syringe 8 |
4.50 |
UG |
2,130 |
889,541 |
|
P |
6322R |
Injection 30ug in 0.3mL syringe 8 |
4.50 |
UG |
2,818 |
1,675,036 |
|
P |
6323T |
Injection 40ug in 0.4mL syringe 8 |
4.50 |
UG |
7,548 |
5,552,442 |
|
P |
6324W |
Injection 50ug in 0.5mL syringe 8 |
4.50 |
UG |
1,053 |
959,368 |
|
P |
6325X |
Injection 60ug in 0.3mL syringe 8 |
4.50 |
UG |
3,250 |
3,580,726 |
|
P |
6326Y |
Injection 100ug in 0.5mL syringe 8 |
4.50 |
UG |
1,915 |
3,455,951 |
|
P |
6365B |
Injection 150ug in 0.3mL syringe 8 |
4.50 |
UG |
882 |
2,304,137 |
|
P |
6438W |
Injection 80ug in 0.4mL syringe 8 |
4.50 |
UG |
1,440 |
2,089,712 |
|
P |
6488L |
Injection 20ug in 0.5mL prefilled injection pen 8 |
4.50 |
UG |
570 |
224,835 |
|
P |
6489M |
Injection 40ug in 0.4mL prefilled injection pen 8 |
4.50 |
UG |
1,943 |
1,361,946 |
|
P |
6490N |
Injection 60ug in 0.3mL prefilled injection pen 8 |
4.50 |
UG |
666 |
718,197 |
|
P |
6491P |
Injection 80ug in 0.4mL prefilled injection pen 8 |
4.50 |
UG |
374 |
525,160 |
|
P |
6492Q |
Injection 100ug in 0.5mL prefilled injection pen 8 |
4.50 |
UG |
379 |
657,909 |
|
P |
6493R |
Injection 150ug in 0.3mL prefilled injection pen 8 |
4.50 |
UG |
188 |
441,510 |
|
OTHER ANTIANAEMIC PREPARATIONS |
|||||||
B03XA01 |
EPOETIN ALPHA |
||||||
P |
6205N |
Injection 3,000 units in 0.3mL syringe 12 |
1.00 |
TE |
112 |
62,679 |
|
P |
6206P |
Injection 4,000 units in 0.4mL syringe 12 |
1.00 |
TE |
509 |
311,753 |
|
P |
6207Q |
Injection 10,000 units in 1mL syringe 12 |
1.00 |
TE |
753 |
1,105,306 |
|
P |
6303R |
Injection 6,000 units in 0.6mL syringe 12 |
1.00 |
TE |
639 |
536,729 |
|
P |
6305W |
Injection 8,000 units in 0.8mL syringe 12 |
1.00 |
TE |
660 |
822,144 |
|
P |
6339P |
Injection 40,000 units in 1mL syringe 2 |
1.00 |
TE |
151 |
375,550 |
|
B03XA01 |
EPOETIN BETA |
||||||
P |
6482E |
Injection 4,000 units in 0.3mL syringe 12 |
1.00 |
TE |
784 |
453,765 |
|
P |
6483F |
Injection 5,000 units in 0.3mL syringe 12 |
1.00 |
TE |
156 |
136,525 |
|
P |
6484G |
Injection 6,000 units in 0.3mL syringe 12 |
1.00 |
TE |
838 |
737,458 |
|
P |
6485H |
Injection 10,000 units in 0.6mL syringe 12 |
1.00 |
TE |
1,103 |
1,453,460 |
|
P |
6486J |
Injection 20,000 units in 0.6mL syringe 12 |
1.00 |
TE |
191 |
572,309 |
|
B03XA03 |
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA |
||||||
P |
9574X |
Injection 30ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
209 |
77,746 |
|
P |
9575Y |
Injection 50ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
353 |
238,397 |
|
P |
9576B |
Injection 75ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
218 |
209,204 |
|
P |
9577C |
Injection 100ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
301 |
357,982 |
|
P |
9578D |
Injection 120ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
251 |
335,277 |
|
P |
9579E |
Injection 200ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
238 |
479,835 |
|
P |
9580F |
Injection 360ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
166 |
558,225 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B05AA06 |
GELATIN SUCCINYLATED |
||||||
P |
8444K |
I.V. infusion 20g per 500mL,500mL |
- |
- |
1,892 |
67,030 |
|
B05AA07 |
HYDROXYETHYLSTARCH |
||||||
P |
9487H |
I.V. infusion 30g per 500mL, 500mL 3 |
- |
- |
1,377 |
49,039 |
|
I.V. SOLUTIONS |
|||||||
SOLUTIONS FOR PARENTERAL NUTRITION |
|||||||
B05BA03 |
GLUCOSE |
||||||
P |
2245E |
I.V. infusion 278mmol per l (5%) 1L |
- |
- |
628 |
11,757 |
|
P |
9444C |
I.V. infusion 139mmol (anhydrous) per 500mL (5%) 500mL 5 |
- |
- |
267 |
3,186 |
|
SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE |
|||||||
B05BB01 |
SODIUM CHLORIDE |
||||||
P |
2260Y |
I.V. infusion 513mmol per l (3%) 1L |
- |
- |
138 |
1,678 |
|
P |
2264E |
I.V. infusion 154mmol per l (0.9% ) 1L |
- |
- |
21,668 |
513,625 |
|
P |
9392H |
I.V. infusion 77mmol per 500mL (0.9%), 500mL 5 |
- |
- |
1,546 |
16,565 |
|
P |
9473N |
I.V. infusion 38.5mmol per 250mL (0.9%) 250mL 5 |
- |
- |
421 |
8,142 |
|
B05BB01 |
SODIUM CHLORIDE COMPOUND |
||||||
P |
2266G |
I.V. infusion 1L |
- |
- |
395 |
11,425 |
|
B05BB02 |
SODIUM CHLORIDE with GLUCOSE |
||||||
P |
2281C |
I.V. infusion 31mmol-222mmol per l (0.18%-4%) 1L |
- |
- |
2,898 |
66,608 |
|
B05BB01 |
SODIUM LACTATE COMPOUND |
||||||
P |
2286H |
I.V. infusion 1L |
- |
- |
13,952 |
236,243 |
|
IRRIGATING SOLUTIONS |
|||||||
SALT SOLUTIONS |
|||||||
B05CB01 |
SODIUM CHLORIDE |
||||||
P |
4460R |
Irrigation solution 9mg per mL (0 .9%) 500mL |
- |
- |
422 |
4,921 |
|
P |
4461T |
Irrigation solution 9mg per mL (0 .9%) 1L |
- |
- |
296 |
3,234 |